<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="153191">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02107690</url>
  </required_header>
  <id_info>
    <org_study_id>2013/2297</org_study_id>
    <nct_id>NCT02107690</nct_id>
  </id_info>
  <brief_title>The Influence of Lidocaine Temperature on Pain During Subcutaneous Administration</brief_title>
  <official_title>The Influence of Lidocaine Temperature on Pain During Subcutaneous Administration</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Norwegian University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>St. Olavs Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Norwegian University of Science and Technology</source>
  <oversight_info>
    <authority>Norway:National Committee for Medical and Health Research Ethics</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will investigate the influence of lidocaine temperature on pain during injection
      of lidocaine. Each participant will receive three injections subcutaneously on the abdomen
      with different temperatures. After each injection, participants will be asked to evaluate
      the pain on a Visual analog scale (0-100 mm). It is anticipated that the pain decreases with
      increasing temperature. The aim of the study is to find a simple method for pain reduction
      that can be used in clinical practice.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Anticipated">May 2014</completion_date>
  <primary_completion_date type="Anticipated">May 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>pain</measure>
    <time_frame>60 seconds</time_frame>
    <safety_issue>No</safety_issue>
    <description>(1) visual analog scale 0-100mm, (2) questionnaire</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Needlestick Injuries</condition>
  <arm_group>
    <arm_group_label>Temperature</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Each participant will receive three lidocaine injections subcutaneously on the abdomen at different temperatures</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Low temperature lidocaine injection</intervention_name>
    <description>4 °C</description>
    <arm_group_label>Temperature</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Room temperature lidocaine injection</intervention_name>
    <description>20 °C</description>
    <arm_group_label>Temperature</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Body temperature lidocaine injection</intervention_name>
    <description>37 °C</description>
    <arm_group_label>Temperature</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18-65 years

        Exclusion Criteria:

          -  Kidney, heart or liver disease

          -  Eczema or psoriasis on injection site

          -  Neuropathy

          -  Regular use of painkillers

          -  Hypersensitivity of Lidocaine

          -  Pregnancy

          -  Diabetes
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vilhjalmur Finsen, prof md</last_name>
    <role>Study Director</role>
    <affiliation>Norwegian University of Science and Technology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Neuroscience, NTNU</name>
      <address>
        <city>Trondheim</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 8, 2014</lastchanged_date>
  <firstreceived_date>April 4, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Injections</keyword>
  <keyword>Temperature</keyword>
  <keyword>Pain</keyword>
  <keyword>Healthy volunteers</keyword>
  <keyword>Lidocaine</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Needlestick Injuries</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
